Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Headlands Research announced its research centers have been selected to participate in AstraZeneca’s upcoming Phase III COVID-19 vaccine trial.
read more
Wednesday, December 20, 2023
Multiply Labs, a cutting-edge robotics company specializing in automated manufacturing systems for personalized drugs, has entered into a non-exclusive partnership with Akron Bio, a leading supplier of essential materials and services for advanced ...
read more
Wednesday, October 11, 2023
Multiply Labs, a robotics company developing automated manufacturing systems to produce individualized drugs (including but not limited to cell therapies), announced that its proof-of-concept robotic system, developed along with UCSF, Cytiva, Thermo ...
read more
Wednesday, August 15, 2018
Mundipharma and Helsinn Group signed a licensing and distribution agreement for the anti-emetic agent Aloxi in Vietnam, extending an international collaboration.
read more
Mural Health, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance, announced a strategic partnership with Clinflash, a ...
read more
Mural Health Technologies, Inc. and ICON announced a partnership to utilize the participant management and payments platform, Mural Link.
read more
Tuesday, January 31, 2023
Mural Health, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance and Ledger Run, a company focused on optimizing ...
read more
Monday, November 14, 2022
Mural Health Technologies announced the launch of its new platform, Mural Link, built to make it easy to participate in global clinical research studies.
read more
Thursday, November 13, 2025
Mursla Bio announced a collaboration with a leading global pharmaceutical company recognized for its expertise in precision medicine and biomarker-guided drug development.
read more
Tuesday, September 03, 2019
BioLife Solutions announced Mustang Bio has adopted BioLife's CryoStor cell freeze media and evo cold chain system for use in current and upcoming clinical trials.
read more
Thursday, October 08, 2020
Mustang Bio has acquired rights to SIRION’s LentiBOOST technology for the development of MB-207.
read more
Tuesday, December 01, 2020
Mustang Bio and Minaris have signed an agreement to enable technology transfer and GMP clinical manufacturing of Mustang’s MB-107 lentiviral gene therapy program for the treatment of XSCID in Europe.
read more
Wednesday, October 17, 2018
MWI Animal Health announced the acquisition of ALLYDVM, a technology company that provides veterinary practices with a range of cloud-based software services.
read more
Mylan has agreed to the terms of a global settlement with Genentech, Inc. and F. Hoffmann-La Roche Ltd. in relation to patents for Herceptin® (trastuzumab), which provides Mylan with global licenses for its trastuzumab product.
read more
Generic drugmaker Mylan announced layoffs of about 15 percent of its workforce at their manufacturing plant in Morgantown, West Virginia.
read more